Journal article 1085 views 190 downloads
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
npj Biofilms and Microbiomes, Volume: 4, Issue: 1
Swansea University Authors: Lydia Powell , Paul Lewis
-
PDF | Version of Record
This article is licensed under a Creative Commons Attribution 4.0 International License.
Download (3.2MB)
DOI (Published version): 10.1038/s41522-018-0056-3
Abstract
Acquisition of a mucoid phenotype by Pseudomonas sp. in the lungs of cystic fibrosis (CF) patients, with subsequent over-production of extracellular polymeric substance (EPS), plays an important role in mediating the persistence of multi-drug resistant (MDR) infections. The ability of a low molecula...
Published in: | npj Biofilms and Microbiomes |
---|---|
ISSN: | 2055-5008 |
Published: |
2018
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa40672 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2018-06-07T19:34:29Z |
---|---|
last_indexed |
2020-07-09T19:01:07Z |
id |
cronfa40672 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-07-09T15:31:07.1250038</datestamp><bib-version>v2</bib-version><id>40672</id><entry>2018-06-07</entry><title>Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides</title><swanseaauthors><author><sid>0e7e702952672bcbfdfd4974199202fb</sid><ORCID>0000-0002-8641-0160</ORCID><firstname>Lydia</firstname><surname>Powell</surname><name>Lydia Powell</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>46dfc22d7468f247c390ba0c6cd8fba6</sid><firstname>Paul</firstname><surname>Lewis</surname><name>Paul Lewis</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-06-07</date><deptcode>BMS</deptcode><abstract>Acquisition of a mucoid phenotype by Pseudomonas sp. in the lungs of cystic fibrosis (CF) patients, with subsequent over-production of extracellular polymeric substance (EPS), plays an important role in mediating the persistence of multi-drug resistant (MDR) infections. The ability of a low molecular weight (Mn=3200 g mol-1) alginate oligomer (OligoG CF-5/20) to modify biofilm structure of mucoid Pseudomonas aeruginosa (NH57388A) was studied in vitro using scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM) with Texas Red (TxRd®)-labelled OligoG and EPS histochemical staining. Structural changes in treated biofilms were quantified using COMSTAT image-analysis software of CLSM z-stack images, and nanoparticle diffusion. Interactions between the oligomers, Ca2+ and DNA were studied using molecular dynamics simulations (MDS), Fourier transform infrared spectroscopy (FTIR) and isothermal titration calorimetry (ITC). Imaging demonstrated that OligoG treatment (&#62;0.5%) inhibited biofilm formation, demonstrating a significant reduction in both biomass and biofilm height (17.8 vs. 5.5 µm; P &#60;0.05). TxRd®-labelled oligomers readily diffused into established (24 h) biofilms. OligoG treatment (≥2%) induced alterations in the EPS of established biofilms; significantly reducing the structural quantities of sugar residues, and extracellular (e)DNA (P &#60;0.05) with a corresponding increase in nanoparticle diffusion (P&#60;0.05) and antibiotic efficacy against established biofilms. ITC demonstrated an absence of rapid complex formation between DNA and OligoG and confirmed the interactions of OligoG with Ca2+ evident in FTIR and MDS. The ability of OligoG to diffuse into biofilms, potentiate antibiotic activity, disrupt DNA-Ca2+-DNA bridges and biofilm EPS matrix highlights its potential for the treatment of biofilm-related infections.</abstract><type>Journal Article</type><journal>npj Biofilms and Microbiomes</journal><volume>4</volume><journalNumber>1</journalNumber><publisher/><issnElectronic>2055-5008</issnElectronic><keywords/><publishedDay>29</publishedDay><publishedMonth>6</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-06-29</publishedDate><doi>10.1038/s41522-018-0056-3</doi><url>http://orca.cf.ac.uk/110780/</url><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-07-09T15:31:07.1250038</lastEdited><Created>2018-06-07T13:30:58.1693335</Created><authors><author><firstname>Lydia</firstname><surname>Powell</surname><orcid>0000-0002-8641-0160</orcid><order>1</order></author><author><firstname>Lydia C.</firstname><surname>Powell</surname><order>2</order></author><author><firstname>Manon F.</firstname><surname>Pritchard</surname><order>3</order></author><author><firstname>Elaine L.</firstname><surname>Ferguson</surname><order>4</order></author><author><firstname>Kate A.</firstname><surname>Powell</surname><order>5</order></author><author><firstname>Shree U.</firstname><surname>Patel</surname><order>6</order></author><author><firstname>Phil D.</firstname><surname>Rye</surname><order>7</order></author><author><firstname>Stavroula-Melina</firstname><surname>Sakellakou</surname><order>8</order></author><author><firstname>Niklaas J.</firstname><surname>Buurma</surname><order>9</order></author><author><firstname>Charles D.</firstname><surname>Brilliant</surname><order>10</order></author><author><firstname>Jack M.</firstname><surname>Copping</surname><order>11</order></author><author><firstname>Georgina E.</firstname><surname>Menzies</surname><order>12</order></author><author><firstname>Paul</firstname><surname>Lewis</surname><order>13</order></author><author><firstname>Katja E.</firstname><surname>Hill</surname><order>14</order></author><author><firstname>David W.</firstname><surname>Thomas</surname><order>15</order></author></authors><documents><document><filename>0040672-03082018152108.pdf</filename><originalFilename>40672.pdf</originalFilename><uploaded>2018-08-03T15:21:08.6300000</uploaded><type>Output</type><contentLength>3439659</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-08-03T00:00:00.0000000</embargoDate><documentNotes>This article is licensed under a Creative Commons Attribution 4.0 International License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2020-07-09T15:31:07.1250038 v2 40672 2018-06-07 Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides 0e7e702952672bcbfdfd4974199202fb 0000-0002-8641-0160 Lydia Powell Lydia Powell true false 46dfc22d7468f247c390ba0c6cd8fba6 Paul Lewis Paul Lewis true false 2018-06-07 BMS Acquisition of a mucoid phenotype by Pseudomonas sp. in the lungs of cystic fibrosis (CF) patients, with subsequent over-production of extracellular polymeric substance (EPS), plays an important role in mediating the persistence of multi-drug resistant (MDR) infections. The ability of a low molecular weight (Mn=3200 g mol-1) alginate oligomer (OligoG CF-5/20) to modify biofilm structure of mucoid Pseudomonas aeruginosa (NH57388A) was studied in vitro using scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM) with Texas Red (TxRd®)-labelled OligoG and EPS histochemical staining. Structural changes in treated biofilms were quantified using COMSTAT image-analysis software of CLSM z-stack images, and nanoparticle diffusion. Interactions between the oligomers, Ca2+ and DNA were studied using molecular dynamics simulations (MDS), Fourier transform infrared spectroscopy (FTIR) and isothermal titration calorimetry (ITC). Imaging demonstrated that OligoG treatment (>0.5%) inhibited biofilm formation, demonstrating a significant reduction in both biomass and biofilm height (17.8 vs. 5.5 µm; P <0.05). TxRd®-labelled oligomers readily diffused into established (24 h) biofilms. OligoG treatment (≥2%) induced alterations in the EPS of established biofilms; significantly reducing the structural quantities of sugar residues, and extracellular (e)DNA (P <0.05) with a corresponding increase in nanoparticle diffusion (P<0.05) and antibiotic efficacy against established biofilms. ITC demonstrated an absence of rapid complex formation between DNA and OligoG and confirmed the interactions of OligoG with Ca2+ evident in FTIR and MDS. The ability of OligoG to diffuse into biofilms, potentiate antibiotic activity, disrupt DNA-Ca2+-DNA bridges and biofilm EPS matrix highlights its potential for the treatment of biofilm-related infections. Journal Article npj Biofilms and Microbiomes 4 1 2055-5008 29 6 2018 2018-06-29 10.1038/s41522-018-0056-3 http://orca.cf.ac.uk/110780/ COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2020-07-09T15:31:07.1250038 2018-06-07T13:30:58.1693335 Lydia Powell 0000-0002-8641-0160 1 Lydia C. Powell 2 Manon F. Pritchard 3 Elaine L. Ferguson 4 Kate A. Powell 5 Shree U. Patel 6 Phil D. Rye 7 Stavroula-Melina Sakellakou 8 Niklaas J. Buurma 9 Charles D. Brilliant 10 Jack M. Copping 11 Georgina E. Menzies 12 Paul Lewis 13 Katja E. Hill 14 David W. Thomas 15 0040672-03082018152108.pdf 40672.pdf 2018-08-03T15:21:08.6300000 Output 3439659 application/pdf Version of Record true 2018-08-03T00:00:00.0000000 This article is licensed under a Creative Commons Attribution 4.0 International License. true eng |
title |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
spellingShingle |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides Lydia Powell Paul Lewis |
title_short |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
title_full |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
title_fullStr |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
title_full_unstemmed |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
title_sort |
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides |
author_id_str_mv |
0e7e702952672bcbfdfd4974199202fb 46dfc22d7468f247c390ba0c6cd8fba6 |
author_id_fullname_str_mv |
0e7e702952672bcbfdfd4974199202fb_***_Lydia Powell 46dfc22d7468f247c390ba0c6cd8fba6_***_Paul Lewis |
author |
Lydia Powell Paul Lewis |
author2 |
Lydia Powell Lydia C. Powell Manon F. Pritchard Elaine L. Ferguson Kate A. Powell Shree U. Patel Phil D. Rye Stavroula-Melina Sakellakou Niklaas J. Buurma Charles D. Brilliant Jack M. Copping Georgina E. Menzies Paul Lewis Katja E. Hill David W. Thomas |
format |
Journal article |
container_title |
npj Biofilms and Microbiomes |
container_volume |
4 |
container_issue |
1 |
publishDate |
2018 |
institution |
Swansea University |
issn |
2055-5008 |
doi_str_mv |
10.1038/s41522-018-0056-3 |
url |
http://orca.cf.ac.uk/110780/ |
document_store_str |
1 |
active_str |
0 |
description |
Acquisition of a mucoid phenotype by Pseudomonas sp. in the lungs of cystic fibrosis (CF) patients, with subsequent over-production of extracellular polymeric substance (EPS), plays an important role in mediating the persistence of multi-drug resistant (MDR) infections. The ability of a low molecular weight (Mn=3200 g mol-1) alginate oligomer (OligoG CF-5/20) to modify biofilm structure of mucoid Pseudomonas aeruginosa (NH57388A) was studied in vitro using scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM) with Texas Red (TxRd®)-labelled OligoG and EPS histochemical staining. Structural changes in treated biofilms were quantified using COMSTAT image-analysis software of CLSM z-stack images, and nanoparticle diffusion. Interactions between the oligomers, Ca2+ and DNA were studied using molecular dynamics simulations (MDS), Fourier transform infrared spectroscopy (FTIR) and isothermal titration calorimetry (ITC). Imaging demonstrated that OligoG treatment (>0.5%) inhibited biofilm formation, demonstrating a significant reduction in both biomass and biofilm height (17.8 vs. 5.5 µm; P <0.05). TxRd®-labelled oligomers readily diffused into established (24 h) biofilms. OligoG treatment (≥2%) induced alterations in the EPS of established biofilms; significantly reducing the structural quantities of sugar residues, and extracellular (e)DNA (P <0.05) with a corresponding increase in nanoparticle diffusion (P<0.05) and antibiotic efficacy against established biofilms. ITC demonstrated an absence of rapid complex formation between DNA and OligoG and confirmed the interactions of OligoG with Ca2+ evident in FTIR and MDS. The ability of OligoG to diffuse into biofilms, potentiate antibiotic activity, disrupt DNA-Ca2+-DNA bridges and biofilm EPS matrix highlights its potential for the treatment of biofilm-related infections. |
published_date |
2018-06-29T03:51:46Z |
_version_ |
1763752548803543040 |
score |
11.037603 |